Authors: | Datko, F. M.; D'Andrea, G.; Dickler, M. N.; Goldfarb, S. B.; Theodoulou, M.; Lake, D.; Fornier, M. N.; Modi, S.; Fasano, J.; Comen, E. A.; Gajria, D.; Moynahan, M. E.; Traina, T. A.; Chen, M.; Hamilton, N.; Patil, S.; Chandarlapaty, S.; Hudis, C.; Dang, C. T. |
Abstract Title: | Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with HER2-overexpressing metastatic breast cancer (MBC) |
Meeting Title: | 49th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
Journal Title: | Journal of Clinical Oncology |
Volume: | 31 |
Issue: | 15 Suppl. |
Meeting Dates: | 2013 May 31-Jun 4 |
Meeting Location: | Chicago, IL |
ISSN: | 0732-183X |
Publisher: | American Society of Clinical Oncology |
Date Published: | 2013-05-20 |
Language: | English |
ACCESSION: | WOS:000335419600111 |
PROVIDER: | wos |
DOI: | 10.1200/jco.2013.31.15_suppl.606 |
Notes: | Meeting Abstract: 606 -- Source: Wos |